Back to search

Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction

Data up to Jan 2025

Published2006
Citations243
References22

Total Citations Per Year

Abstract

References (22)

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

2003 • 3,707 citations

Circulating angiogenic factors and the risk of preeclampsia*

2004 • 2,591 citations

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.

1993 • 1,391 citations

Pre-eclampsia

2005 • 1,080 citations

Neutralization of Circulating Vascular Endothelial Growth Factor (VEGF) by Anti-VEGF Antibodies and Soluble VEGF Receptor 1 (sFlt-1) Induces Proteinuria

2003 • 519 citations

Overexpression of the Soluble Vascular Endothelial Growth Factor Receptor in Preeclamptic Patients: Pathophysiological Consequences

2003 • 453 citations

Pregnancy outcomes in healthy nulliparas who developed hypertension

2000 • 428 citations

Elevated Serum Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR-1) Levels in Women with Preeclampsia

2003 • 396 citations

Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia

2004 • 362 citations

Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia

2005 • 337 citations

Pitfalls in the Measurement of Circulating Vascular Endothelial Growth Factor

2001 • 325 citations

Fetal responses to placental insufficiency: an update

2004 • 279 citations

The role of uterine artery Doppler in predicting adverse pregnancy outcome

2004 • 247 citations

Soluble fms-Like Tyrosine Kinase 1 Is Increased in Preeclampsia But Not in Normotensive Pregnancies with Small-for-Gestational-Age Neonates: Relationship to Circulating Placental Growth Factor

2005 • 242 citations

A comprehensive study of oxidative stress and antioxidant status in preeclampsia and normal pregnancy

2004 • 220 citations

Release and Complex Formation of Soluble VEGFR-1 from Endothelial Cells and Biological Fluids

2000 • 217 citations

The placental problem: linking abnormal cytotrophoblast differentiation to the maternal symptoms of preeclampsia.

2004 • 201 citations

Circulating endothelial cell adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia

1997 • 156 citations

Term preeclampsia is associated with minimal histopathological placental features regardless of clinical severity

2005 • 91 citations

Increased uterine artery vascular impedance is related to adverse outcome of pregnancy but is present in only one‐third of late third‐trimester pre‐eclamptic women

2005 • 81 citations

Atherogenic lipoprotein subfraction profile in preeclamptic women with and without high triglycerides: different pathophysiologic subsets in preeclampsia

2005 • 43 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...